Search Results

Function Health Secures $450 Million in Funding to Expand Laboratory Testing and Medical Imaging Platform

U.S. health technology company Function Health recently secured $450 million in growth funding from General Catalyst's Customer Value Fund. The company stated that the funds will be used to expand user coverage of its testing and medical imaging platform. Function Health launched as a beta version in 2023, with a platform integrating laboratory testing, medical imaging, and health data analytics services. Its membership includes over 160 laboratory tests, with testing scheduled twice a year, and annual plans starting at $365. Testing coverage encompasses cardiovascular health, hormones, thyroid and kidney function, inflammation, nutritional levels, and certain cancers...

2026-08-16

Society of Interventional Radiology Launches Framework to Quantify the Value of Interventional Radiology

The Society of Interventional Radiology (SIR) is developing a framework to measure the clinical and economic value of interventional radiology, aiming to expand the specialty's role in health system planning, payment reimbursement, and patient management. According to reports, SIR has partnered with triLumen Health Partners to develop a strategic roadmap focused on identifying and quantifying the contributions of interventional radiology in academic medical centers, community hospitals, and outpatient settings. The project is expected to inform SIR's strategic planning extending through 2029 and beyond. Dr. Saher S. Sabri, SIR President, stated that interventional radiology is currently often evaluated using metrics such as procedure volume and relative value units, but these metrics may not fully reflect its role in long-term clinical care, perioperative management, and overall health system cost control...

2026-08-16

CGN Medical and West China Hospital of Sichuan University Sign Proton Therapy Innovation Technology Cooperation Agreement

On August 14, the 32nd China International Medical Instruments and Equipment Exhibition & Technology Exchange Conference (China-Hospeq 2026) opened at the China National Convention Center in Beijing. CGN Medical was invited to exhibit under the theme of "Precision Radiotherapy · Nuclear Medicine Empowerment," showcasing achievements in the healthcare sector including the Hezhi® proton therapy system and the Hejia® germanium-gallium generator. The exhibits covered radiotherapy solutions, new medical isotopes, SiPM chips for molecular imaging, radiation protection, and medical device sterilization. On the first day of the exhibition, representatives from relevant departments and institutions visited the CGN Medical booth, learning about CGN's product layout and technological progress in the nuclear medicine field, and showing interest in its efforts in the domestic substitution of high-end medical equipment...

2026-08-15

OXOS Medical and Others Deploy Portable X-Ray Systems to Disaster Zones in Venezuela

On August 12, U.S.-based OXOS Medical announced that it will partner with the non-profit organization Love & Life Foundation and the rapid response and disaster intervention team MEDIC Corps to deploy the MC2 portable X-ray system to Venezuela to support post-disaster humanitarian medical relief efforts. According to reports, the strong earthquake that struck Venezuela on June 24 has caused more than 16,000 injuries. For medical teams treating patients on the front lines in rubble and disaster zones, timely assessment of injuries such as fractures and chest or abdominal trauma is critical, but in areas with damaged infrastructure and limited resources, routine medical imaging examinations are often difficult to obtain in a timely manner. The materials also cite World Health Organization data stating...

2026-08-13

Maistop Completes Pre-A Round Financing to Advance Medical Radionuclide Industrialization via Electron Accelerator Method

August 12 news, Xi'an Maistop Technology Co., Ltd. recently completed its Pre-A round of financing, with investors including the Central Enterprise Strategic Emerging Fund and Guoxin Venture Capital Fund, both under China Reform Holdings Corporation. The proceeds from this round will primarily be used for site construction, equipment procurement, technology R&D, and daily operations. Founded in 2019, Maistop is a technology enterprise engaged in the R&D and production of medical radionuclides as well as nuclear medicine technical services. The company focuses on the preparation of medical radionuclides via the electron accelerator photonuclear reaction method, with core products including Actinium-225, Lead-212, Copper-67, and Molybdenum-99. Among these, Actinium-225 is a scarce radionuclide of significant interest in alpha-emitting nuclide targeted therapy, with relatively strong global clinical demand...

2026-08-13

Southwest University of Science and Technology Releases Medical Radioactive Waste Treatment Technology Covering Liquid, Gas, and Solid Waste Management

On August 10, the Mianyang Science and Technology City Strategic Development Research Center held an online innovation achievement release conference, unveiling a medical radioactive waste treatment technology developed by the School of National Defense Science and Technology / School of Nuclear Science and Technology at Southwest University of Science and Technology. The technology targets radioactive contaminants including liquid waste, off-gas, and solid waste generated during nuclear medicine diagnosis and treatment, offering a full-chain comprehensive treatment solution. The conference attracted 87,000 experts in the nuclear medicine field, departmental representatives, and enterprise users. With the rapid development of the domestic nuclear medicine industry, insufficient radioactive waste disposal capacity has gradually become a key issue facing the industry's safe expansion. Relevant data show that over 96% of nuclear medicine departments nationwide are constrained by decay tank capacity...

2026-08-13

Leshan Accelerates Construction of Medical Isotope Production Base to Promote Domestic Substitution of "Anti-Cancer Nuclear Drugs"

On August 11, at the Leshan special press conference of "Myriad Scenes in Sichuan · Embarking on the '15th Five-Year Plan'", Leshan Mayor Zhao Yingchun stated that Leshan is accelerating the construction of the largest and most comprehensive medical isotope production base in China. Upon completion, the project will help break the foreign monopoly and import dependence on related products, promote the domestic substitution of anti-cancer nuclear drugs, and enable more patients to access domestically produced drugs with lower prices and better efficacy. Zhao Yingchun noted that during the "14th Five-Year Plan" period, Leshan has focused on building the "China Green Silicon Valley", a world-class tourist destination, and a major regional transportation and logistics hub in the province, continuously promoting high-quality development, with its economic output surpassing 250 billion yuan...

2026-08-12

LG Electronics Launches FDA-Approved 40-Inch Diagnostic Monitor for B2B Medical Imaging Market

LG Electronics announced on August 12 that it has launched a new 40-inch diagnostic monitor, the 40HT513D, targeting the business-to-business (B2B) medical display market. The product has received approval from the U.S. Food and Drug Administration (FDA) and is primarily intended for medical image interpretation. According to the company, the 40HT513D features a curved IPS black panel with a 21:9 aspect ratio and a resolution of 5120×2160, delivering approximately 11 million pixels. LG Electronics stated that this design consolidates image reading tasks that previously required three 3-megapixel monitors into a single screen. Physicians can simultaneously view and compare current and historical images from X-ray, CT scans, and MRI scans on the same display...

2026-08-12

US Oak Ridge National Laboratory Restarts Tungsten-188/Rhenium-188 Generator Production to Support Targeted Cancer Therapy Research

The US Department of Energy's Oak Ridge National Laboratory (ORNL) recently restarted and upgraded its tungsten-188/rhenium-188 (W-188/Re-188) generator manufacturing operations to meet the demand for the rare medical isotope rhenium-188 in targeted cancer therapy research. The laboratory last manufactured such generators in 2011. Radiochemist Becca Hores demonstrated the assembly process of the W-188/Re-188 generator. Depending on radioactivity levels, these generators must be assembled in gloveboxes or hot cells. Image credit: Maggie Gregg/Oak Ridge National Laboratory, US Department of Energy. Rhenium-188 is produced by the radioactive decay of tungsten-188. ORNL irradiates tungsten-186 in the High Flux Isotope Reactor (HFIR) to produce tungsten-188...

2026-08-12

Dong Nai Province, Vietnam: Nuclear Medicine Applications Drive Modern Medical Development, Focusing on Early Cancer Diagnosis and Precision Treatment

In the development of modern medicine, atomic energy technology is moving from the laboratory to the clinical frontline, becoming an important pillar for early disease screening, precise diagnosis, and effective treatment. In recent years, Dong Nai Province has continuously applied nuclear medicine technology to medical examinations and treatments, particularly in areas such as cancer, stroke, traumatic brain injury, cardiovascular diseases, and bone and joint injuries. Through equipment such as X-ray, gamma rays, CT, and MRI, doctors can observe deep structures and lesions of the human body within a relatively short time, giving patients the opportunity for earlier detection and faster intervention. At Dong Nai General Hospital, approximately 500 patients undergo X-ray or related imaging examinations each day, with digital X-ray systems and multi-slice spiral C...

2026-08-12

Huaneng Changjiang Nuclear Power Company Signs Medical Cooperation Agreement with Hainan Western Central Hospital

Recently, Huaneng Hainan Changjiang Nuclear Power Co., Ltd. signed a medical cooperation agreement with Hainan Western Central Hospital, comprehensively strengthening the health and safety defense line for enterprise employees and safeguarding nuclear power production safety. The two parties agreed to leverage the hospital's high-quality medical resources to open a green channel for employees' emergency medical treatment, carry out routine occupational health examinations and health science education, establish a rapid transport and treatment linkage mechanism for sudden injuries or illnesses at the plant site, and efficiently handle various on-site emergency medical situations. After the signing ceremony, relevant personnel from Huaneng Changjiang Nuclear Power Company visited the Emergency Department and Outpatient Building at the Baimajing Binhai Campus, gaining detailed insights into emergency treatment procedures, rescue equipment configuration, and emergency rescue operation models, and engaging in discussions with medical staff on topics such as on-site industrial injury handling and emergency medical response to sudden health events.

2026-08-11

Argentine CNEA Expert Appointed Vice Chair of European Working Group on Nuclear Medicine Isotope Supply Security

The Argentine National Atomic Energy Commission (CNEA) recently announced that Daniel Sestao, an engineer and the institution's radioisotope production manager, has been appointed Vice Chair of the Supply Security Working Group of the European Association of Nuclear Medicine. CNEA, which operates under the Nuclear Affairs Secretariat of Argentina's Ministry of Economy, views this appointment as recognition of its technical capabilities in nuclear medicine and its role in international collaboration. The Supply Security Working Group is composed of international experts and focuses on the continuity and sustainability of the medical radioisotope supply chain, covering strategic isotopes such as molybdenum-99, technetium-99m, and lutetium-177. These radioisotopes are widely used in the diagnosis and treatment of tumors and complex diseases, forming a critical component of the nuclear medicine system...

2026-08-11

South Korea to Launch Real-Time Query System for CT and MRI Records in December to Reduce Duplicate Tests for Patients Transferring Hospitals

The Health Insurance Review and Assessment Service (HIRA) of South Korea announced on August 10 that it has established the "Appropriate Medical Utilization Review Committee" and, at its first meeting, included computed tomography (CT) and magnetic resonance imaging (MRI) examinations in the review scope of the real-time medical utilization management program. According to the plan, the program will be managed through the "Medical Care Benefit Details Confirmation System" following approval by the Minister of Health and Welfare. The system, built pursuant to Article 41-6 of the revised National Health Insurance Act, is expected to officially operate starting December 24. Once the system is in place, medical personnel will be able to query in real time the timing and relevant records of patients' CT and MRI examinations at other medical institutions before the patients undergo examinations, thereby reducing...

2026-08-11

Rosatom launches project to bring medical students to closed nuclear cities

Rosatom and the Russian Student Teams (RSO) will launch a new medical project in Russia's closed nuclear cities starting in 2027, attracting medical students to work there. Mikhail Kiselev, Chairman of the RSO Supervisory Board and State Duma deputy, announced this to reporters at an event at the Siberian Chemical Combine. Kiselev stated: Starting next year, we plan to launch a large-scale medical project in nuclear cities together with Rosatom, the Russian Student Teams, the Federal Medical-Biological Agency, the Russian Youth Affairs Agency, and the Russian Ministry of Health. This will help systematically attract medical students...

2026-08-11

Fractionated radiotherapy did not significantly alter surface properties of two types of dental restorative composites

On August 5, a recently published in vitro study showed that under a simulated clinical head and neck cancer radiotherapy regimen, the surface microhardness and roughness of two modern dental restorative composites did not change significantly. The study focused on the effects of therapeutic ionizing radiation on the durability of dental restorative materials. After head and neck cancer patients receive radiotherapy, the oral environment may change, including reduced saliva secretion, mucositis, radiation caries, and other issues, which may affect the surface condition and long-term performance of restorations. To this end, the research team selected Giomer resin composite based on glass ionomer technology and Or...

2026-08-10